{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:23:09Z","timestamp":1783110189172,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejpb.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T12:01:38Z","timestamp":1583496098000},"page":"108-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Reversion of arterial calcification by elastin-targeted DTPA-HSA nanoparticles"],"prefix":"10.1016","volume":"150","author":[{"given":"Jacqueline","family":"Keuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Mulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Riehemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Rutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.03.007_b0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijcard.2017.01.132","article-title":"Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis","volume":"236","author":"Chaikriangkrai","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejpb.2020.03.007_b0010","doi-asserted-by":"crossref","first-page":"e10461","DOI":"10.1097\/MD.0000000000010461","article-title":"Lung cancer screening CT-based coronary artery calcification in predicting cardiovascular events: A systematic review and meta-analysis","volume":"97","author":"Fan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejpb.2020.03.007_b0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fcvm.2018.00196","article-title":"Endogenous calcification inhibitors in the prevention of vascular calcification: a consensus statement from the COST Action EuroSoftCalcNet","volume":"5","author":"B\u00e4ck","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"issue":"2013","key":"10.1016\/j.ejpb.2020.03.007_b0020","first-page":"442","article-title":"Mechanisms of arterial calcifications and consequences for cardiovascular function","volume":"3","author":"London","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ejpb.2020.03.007_b0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11914-017-0370-3","article-title":"Inherited arterial calcification syndromes: Etiologies and treatment concepts","volume":"15","author":"Nitschke","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.ejpb.2020.03.007_b0030","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1080\/15384101.2015.1007809","article-title":"The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene","volume":"14","author":"Li","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejpb.2020.03.007_b0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(99)00370-1","article-title":"Desolvation process and surface characterisation of protein nanoparticles","volume":"194","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.03.007_b0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2014.09.029","article-title":"Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects","volume":"196","author":"Lei","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.03.007_b0045","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbrc.2004.08.223","article-title":"Pharmacological activity of DTPA linked to protein-based drug carrier systems","volume":"323","author":"Michaelis","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejpb.2020.03.007_b0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13181-013-0347-2","article-title":"Current use of chelation in American health care","volume":"9","author":"Wax","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.ejpb.2020.03.007_b0055","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00223-013-9780-0","article-title":"Efficacy of reversal of aortic calcification by chelating agents","volume":"93","author":"Lei","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ejpb.2020.03.007_b0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ahj.2011.10.002","article-title":"Design of the trial to assess chelation therapy (TACT)","volume":"163","author":"Lamas","year":"2012","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejpb.2020.03.007_b0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2013.2107","article-title":"Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial","volume":"309","author":"Lamas","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejpb.2020.03.007_b0070","first-page":"627","article-title":"Effects of intravenous EDTA treatment on serum parathyroid hormone (1\u201384) and biochemical markers of bone turnover","volume":"40","author":"Guldager","year":"1993","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.ejpb.2020.03.007_b0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3181\/00379727-84-20645","article-title":"Use of ethylene diamine tetra acetic acid in hypercalcemic patients","volume":"84","author":"Holland","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ejpb.2020.03.007_b0080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/ki.2008.455","article-title":"Sodium thiosulfate prevents vascular calcifications in uremic rats","volume":"74","author":"Pasch","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejpb.2020.03.007_b0085","first-page":"17","article-title":"Nanoparticles - a new colloidal drug delivery system","volume":"53","author":"Marty","year":"1978","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ejpb.2020.03.007_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5173(99)00420-2","article-title":"Desolvation process and surface characteristics of HSA-nanoparticles","volume":"196","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.03.007_b0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2017.03.006","article-title":"Modifying plasmid-loaded HSA-nanoparticles with cell penetrating peptides - cellular uptake and enhanced gene delivery","volume":"522","author":"Mesken","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.03.007_b0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.6836304","article-title":"Radioactive labeling of antibody: A simple and efficient method","volume":"20","author":"Hnatowich","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2020.03.007_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-5173(00)00590-1","article-title":"Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups","volume":"211","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.03.007_b0110","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1246\/bcsj.56.2621","article-title":"Determination of ethylenediaminetetraacetic acid and nitrilotriacetic acid as their iron(III)-complexes by reversed phase high performance liquid chromatography","volume":"56","author":"Yamaguchi","year":"1983","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejpb.2020.03.007_b0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0003-2697(67)90273-4","article-title":"A new method for determining micro quantities of calcium in biological materials","volume":"20","author":"Sarkar","year":"1967","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2020.03.007_b0120","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/hmg\/ddi183","article-title":"Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum","volume":"14","author":"Gorgels","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"Suppl","key":"10.1016\/j.ejpb.2020.03.007_b0125","first-page":"157","article-title":"A new breed of mouse showing multiple osteochondral lesions\u2013twy mouse","volume":"21","author":"Hosoda","year":"1981","journal-title":"Ryumachi [Rheumatism]"},{"key":"10.1016\/j.ejpb.2020.03.007_b0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/956","article-title":"Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine","volume":"19","author":"Okawa","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejpb.2020.03.007_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/439389","article-title":"Antibody-Conjugated Nanoparticles for Biomedical Applications","volume":"2009","author":"Arruebo","year":"2009","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2020.03.007_b0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.03.007_b0145","first-page":"8","article-title":"Surface-modified biodegradable nano- and microspheres. I. Preparation and characterization","volume":"39","author":"Roser","year":"1993","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.03.007_b0150","series-title":"Thermodynamics - Fundamentals and Its Application in Science","first-page":"371","article-title":"Thermodynamics and kinetics in the synthesis of monodisperse nanoparticles","author":"Hwang","year":"2017"},{"key":"10.1016\/j.ejpb.2020.03.007_b0155","unstructured":"M. Michaelis, Entwicklung und in-vitro-Testung von Arzneistofftr\u00e4gersystemen f\u00fcr antivirale und antitumorale Arzneistoffe, in: Fachbereich Chemische und pharmazeutische Wissenschaften, Johann Wolfgang-Goethe Universit\u00e4t, Frankfurt, 2001."},{"key":"10.1016\/j.ejpb.2020.03.007_b0160","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1021\/ac501536z","article-title":"How antibody surface coverage on nanoparticles determines the activity and kinetics of antigen capturing for biosensing","volume":"86","author":"Saha","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2020.03.007_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future","volume":"47","author":"M\u00fcller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.03.007_b0170","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1152\/jappl.1967.22.4.772","article-title":"Influence of plasma osmolarity on the rheology of human blood","volume":"22","author":"Meiselmann","year":"1967","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejpb.2020.03.007_b0175","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2215\/CJN.07400715","article-title":"Acid-base homeostasis","volume":"10","author":"Hamm","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejpb.2020.03.007_b0180","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/ma11030394","article-title":"Protein-based nanoparticle preparation via nanoprecipitation method","volume":"11","author":"Tarhini","year":"2018","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ejpb.2020.03.007_b0185","unstructured":"J. Look, Neuartige Liganden-modifizierte Nanopartikel als Tr\u00e4gersysteme f\u00fcr Nukleins\u00e4uren, in: Institut f\u00fcr Pharmazeutische Technologie und Biopharmazie, Westf\u00e4lische Wilhelms-Universit\u00e4t, M\u00fcnster, 2015."},{"key":"10.1016\/j.ejpb.2020.03.007_b0190","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejpb.2020.03.007_b0195","doi-asserted-by":"crossref","first-page":"25968","DOI":"10.1074\/jbc.272.41.25968","article-title":"Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway","volume":"272","author":"Tiruppathi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.03.007_b0200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.107.1.231","article-title":"Identification of albumin-binding proteins in capillary endothelial cells","volume":"107","author":"Ghinea","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2020.03.007_b0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ceca.2005.03.006","article-title":"Extracellular calcium is required for the maintenance of plasma membrane integrity in nucleated cells","volume":"38","author":"Orlov","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejpb.2020.03.007_b0210","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.nano.2014.02.002","article-title":"Nanoparticle targeting to diseased vasculature for imaging and therapy","volume":"10","author":"Sinha","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2020.03.007_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940600007X","article-title":"Elastic fibres in health and disease","volume":"8","author":"Kielty","year":"2006","journal-title":"Expert Rev. Mol. Med."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:36:27Z","timestamp":1760546187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120300631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":43,"alternative-id":["S0939641120300631"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.03.007","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversion of arterial calcification by elastin-targeted DTPA-HSA nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}